United StatesLevothyroxine Sodium Tablets, USP, Thyro-Tabs 150 mcg, 1000-tablet bottles (NDC 47781-662-10), Lot MHA21825, exp 12/31/2027, distributed by Alvogen in the United States, are affected. The product was recalled after a pharmacy reported one bottle from this lot contained 88 mcg tablets instead of 150 mcg tablets.
What's being recalled
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
Recalling firm: Alvogen, Inc, Morristown, NJ, United States.
How to identify it
Lot # MHA21825, Exp Date: December 31, 2027
The hazard
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)